TR XIDATIN AGONISTS AND ANTAGONISTS TREATMENT OF METABOLIC DISORDERS

Details for Australian Patent Application No. 2002321767 (hide)

Owner GENSET S.A.

Inventors LUCAS, John; DIALYNAS, Deno; BRIGGS, Kristen

Pub. Number AU-A-2002321767

PCT Number PCT/IB02/03404

PCT Pub. Number WO2003/013580

Priority 60/310,088 03.08.01 US

Filing date 31 July 2002

Wipo publication date 24 February 2003

International Classifications

A61K 038/17 Medicinal preparations containing peptides - from animals

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61P 003/00 Drugs for disorders of the metabolism

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/310,088 03.08.01 US

19 June 2003 Application Open to Public Inspection

  Published as AU-A-2002321767

6 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002321768-GMG-2 polynucleotides and polypeptides and uses thereof

2002321766-AGONISTS AND ANTAGONISTS OF OBESINGEN FOR THE TREATMENT OF METABOLIC DISORDERS